Follicular Helper T-Cell Lymphoma — Trials

Follicular Helper T-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 10
Ph III recruiting: 2
Growth YoY: —
Industry share: 24%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05821192	Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.	unknown	N/A	34	Ou Bai, MD/PHDOTHER	1	Apr 20, 2023	clinicaltrials
NCT04319601	Rituximab Combined With Chidamide and Lenalidomide for r/r AITL(AITL)	unknown	N/A	26	Zhejiang Cancer HospitalOTHER	1	Mar 24, 2021	clinicaltrials